A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia
Clinical trial NCT04457310 · COMPLETED
Trial details
- NCT number
- NCT04457310
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-02
- Primary completion
- 2024-03-22
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.